Chi-Un Pae, MD, PhD

Cognitive Dysfunction in Psychiatric Illness: A Neglected Domain

March 25, 2015

Chi-Un Pae, Prakash S. Masand

Article

A Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study of Milnacipran for Chronic Radicular Pain (Sciatica) Associated With Lumbosacral Disc Disease

August 15, 2014

Here, review results from a 10-week study that compared the pain-relieving effects of milnacipran, an SNRI, to that of placebo in patients with lumbosacral disc disease. Nerve pain in...

Ashwin A. Patkar, Chi-Un Pae, David M. Marks

Original Research

Safety of Selegiline Transdermal System in Clinical Practice: Analysis of Adverse Events From Postmarketing Exposures

May 15, 2012

Michael E. Thase, Ashwin A. Patkar, Chi-Un Pae, et al

Letter to the Editor

Augmentation of Dopaminergic Agents for Major Depressive Disorder

May 15, 2009

Ashwin A. Patkar, Chi-Un Pae, Prakash S. Masand

Original Research

History of Depressive and Anxiety Disorders and Paroxetine Response in Patients With Irritable Bowel Syndrome: Post Hoc Analysis From a Placebo-Controlled Study

October 15, 2008

Ashwin A. Patkar, Chi-Un Pae, Prakash S. Masand, et al

Original Research

An Open-Label, Rater-Blinded, Flexible-Dose, 8-Week Trial of Escitalopram in Patients With Major Depressive Disorder With Atypical Features

June 16, 2008

Ashwin A. Patkar, Chi-Un Pae, Prakash S. Masand, et al

Original Research

Rapid Versus Conventional Initiation of Quetiapine in the Treatment of Schizophrenia: A Randomized, Parallel-Group Trial

March 15, 2007

Ashwin A. Patkar, Chi-Un Pae, Prakash S. Masand, et al

Original Research

Effects of Olanzapine on Prolactin Levels of Female Patients With Schizophrenia Treated With Risperidone

May 12, 2002

Chi-Un Pae, Ruth A. Dickson, Kwang-Soo Kim, et al

Cognitive Dysfunction in Psychiatric Illness: A Neglected Domain

A Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study of Milnacipran for Chronic Radicular Pain (Sciatica) Associated With Lumbosacral Disc Disease

Safety of Selegiline Transdermal System in Clinical Practice: Analysis of Adverse Events From Postmarketing Exposures

Augmentation of Dopaminergic Agents for Major Depressive Disorder

History of Depressive and Anxiety Disorders and Paroxetine Response in Patients With Irritable Bowel Syndrome: Post Hoc Analysis From a Placebo-Controlled Study

An Open-Label, Rater-Blinded, Flexible-Dose, 8-Week Trial of Escitalopram in Patients With Major Depressive Disorder With Atypical Features

Rapid Versus Conventional Initiation of Quetiapine in the Treatment of Schizophrenia: A Randomized, Parallel-Group Trial

Effects of Olanzapine on Prolactin Levels of Female Patients With Schizophrenia Treated With Risperidone

ELSEWHERE:

FOLLOW US:

Chi-Un Pae, MD, PhD

Cognitive Dysfunction in Psychiatric Illness: A Neglected Domain

A Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study of Milnacipran for Chronic Radicular Pain (Sciatica) Associated With Lumbosacral Disc Disease

Safety of Selegiline Transdermal System in Clinical Practice: Analysis of Adverse Events From Postmarketing Exposures

Augmentation of Dopaminergic Agents for Major Depressive Disorder

History of Depressive and Anxiety Disorders and Paroxetine Response in Patients With Irritable Bowel Syndrome: Post Hoc Analysis From a Placebo-Controlled Study

An Open-Label, Rater-Blinded, Flexible-Dose, 8-Week Trial of Escitalopram in Patients With Major Depressive Disorder With Atypical Features

Rapid Versus Conventional Initiation of Quetiapine in the Treatment of Schizophrenia: A Randomized, Parallel-Group Trial

Effects of Olanzapine on Prolactin Levels of Female Patients With Schizophrenia Treated With Risperidone

Learn More About Psychedelics in Psychiatry

Subscribe to readmore articles

Subscribe to read
more articles